ACM
MBII

Azimuth Capital Management’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Azimuth Capital Management’s Portfolio MBII Stock Details MBII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-35,000
Closed -$40K – 291
2017
Q3 		$40K Buy
+35,000
New +$39.8K ﹤0.01% 284

Other funds holding MBII

WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CPA
Capital Planning Advisors Roseville, California $692M AUM 21.81% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Azimuth Capital Management's MBII Position: Q4 2017 in Review

Azimuth Capital Management sold out of Marrone Bio Innovations, Inc. (MBII) in Q4 2017, closing a stake of 35,000 shares — an estimated $40K sold.

Azimuth Capital Management first reported a position in MBII in Q3 2017 and held it in 1 quarter. The position peaked at $40K in Q3 2017. 19 funds tracked by Wall St. Rank hold MBII as of Q4 2017.

  • Azimuth Capital Management reported no remaining Marrone Bio Innovations, Inc. position as of Q4 2017 after selling out during the quarter.
  • Azimuth Capital Management sold 35,000 Marrone Bio Innovations, Inc. shares in Q4 2017, an estimated $40K.
  • Azimuth Capital Management first reported a position in Marrone Bio Innovations, Inc. in Q3 2017 and held it in 1 quarter.
  • Azimuth Capital Management's Marrone Bio Innovations, Inc. position peaked at $40K in Q3 2017.
  • 19 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q4 2017.

Based on Azimuth Capital Management's 13F filing for Q4 2017, filed 12 Feb 2018.